Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Forward Science's annualized net income for the quarter that ended in Dec. 2025 was NT$-90.5 Mil. Forward Science's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was NT$359.0 Mil. Therefore, Forward Science's annualized ROE % for the quarter that ended in Dec. 2025 was -25.21%.
The historical rank and industry rank for Forward Science's ROE % or its related term are showing as below:
ROCO:7530'
s ROE % Range Over the Past 10 Years
Min: -23.07 Med: -9.79 Max: 3.85
Current: -23.07
During the past 8 years, Forward Science's highest ROE % was 3.85%. The lowest was -23.07%. And the median was -9.79%.
ROCO:7530's ROE % is ranked worse than 92.14% of 3002
companies
in the Industrial Products industry
Industry Median: 5.85
vs ROCO:7530: -23.07
Forward Science (ROCO:7530) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Forward Science ROE % Related Terms
Forward Science ROE % Historical Data
* Premium members only.
The historical data trend for Forward Science's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Forward Science's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forward Science ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Forward Science's ROE % distribution charts can be found below:
* The bar in red indicates where Forward Science's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Forward Science (ROCO:7530) has a ROE % of -25.21% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Forward Science and its competitors. According to the industry distribution chart, Forward Science ranks #2766 out of 3002 companies in the Industrial Products industry, placing it in the top 92.1%.
Is Forward Science's ROE % too high?
Forward Science's current ROE % is -25.21%. Based on the distribution chart, Forward Science ranks #2766 out of 3002 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Forward Science has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Forward Science's ROE % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Forward Science ranks #2766 out of 3002 companies for ROE %. This places Forward Science in the lower half of its industry. The industry median ROE % is 5.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.85, based on 3,002 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Forward Science and its competitors. For the Industrial Products industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forward Science's current ROE % is -25.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forward Science stock overvalued right now?
Based on GuruFocus' analysis, Forward Science (ROCO:7530) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$14.15, compared to a current price of NT$38.55 — trading 172.4% above its estimated fair value. The current ROE % is -25.21%. Forward Science's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Forward Science (ROCO:7530), the current ROE % is -25.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Forward Science (ROCO:7530) Overvalued in 2026?
Based on GuruFocus' analysis, Forward Science stock appears to be overvalued.
The current stock price of NT$38.55 is trading 172.4% above its estimated GF Value™ of NT$14.15.
GuruFocus considers Forward Science to be Significantly Overvalued.
Key valuation signals for ROCO:7530:
ROE %: -25.21%
GF Value™: NT$14.15 vs. price of NT$38.55 (172.4% above fair value)
No single metric tells the full story. See the ROCO:7530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Forward Science Corp is engaged in the manufacturing and maintenance of vacuum pumps. It is also involved in precision parts manufacturing that includes Stainless Processing, Aluminum Processing, Casting Processing, and Metal Finishing among others. Geographically, the company generates the majority of its revenue from Taiwan.
38GF Score
Get the complete analysis for ROCO:7530
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7530 has been successfully added to your 
